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This study aims at genetic characterization and phylogenetic relationships of Nocardia brasiliensis focusing by using housekeeping
rrs, hsp65, and sodA genes. N. brasiliensis is the species responsible for 80% of cases of actinomycetoma, one form of cutaneous
nocardiosis which occurs mainly in tropical regions reaching immunocompetent patients in which the disease can lead to
amputation. We analyze 36 indigenous cases of N. brasiliensis that happened in France. Phylogenetic analysis targeting rrs gene
showed no robustness at phylogenetic nodes level. However, the use of a concatenation of hsp65 and sodA genes showed that the
tested strains surprisingly ranked in 3 well-defined genotypes. Genotypes 2 and 3 were phylogenetically closer to each other and
both diverged from genotype 1 sustained by a high bootstrap of 81%. This last genotype hosts all the cases of pulmonary forms (3),
the sole cerebral form, and almost all the cases of immunocompromised patients (3 out of 4). Moreover, excepting one of them,
all the strains belonging to this group present a susceptibility to imipenem which is not the case in the other genotypes that rarely
count among them strains being susceptible to this drug. The haplotype diversity (Hd) of hsp65 (0.927) and sodA (0.885) genes
was higher than that of rrs (0.824). For this gene, we obtained 16 polymorphic sites whereas, for hsp65 and sodA genes, up to 27
and 29 were identified, respectively.This study reveals that these two genes have an important genetic discriminatory power for the
evaluation of the intraspecies genetic variability ofN. brasiliensis and they may be useful for identification purposes at species level.
This study also reveals the possible existence of a new species harbored by genotype 1.
1. Introduction
Nocardia is a genus belonging to the aerobic actino-
mycetes group of bacteria which are Gram-positive bacilli
and showing branching filamentous forms [1]. They are
saprophytic ubiquitous bacteria which can be found in
several environments such as fresh water and saltwater,
soil, dust, decaying vegetation, and decaying fecal deposits
from animals [1]. Nevertheless, these environmental bac-
teria can be opportunistic pathogens and lead to human
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infectious diseases called “nocardiosis” [2]. Nocardiosis can
be discriminated into two groups: invasive infection, mainly
caused by N. asteroides, presenting commonly as pneumonia
in patients who are immunocompromised, have underlying
chronic lung disease, and are with a possible dissemination
to other organs [3], and cutaneous infection via a cut
or abraded skin, which can be manifest clinically as (i)
abscess and cellulitis, (ii) lymphangitis, (iii) skin infection
secondary to dissemination, and (iv) actinomycetoma. This
latter group is the most amazing infection due to their
severity characterized by the presence of tumefaction, subcu-
taneous nodules, destructive granulomata, fistulas, and pus
[2, 4].
N. brasiliensis is the species isolated from the major-
ity (approximately 80%) of cases of cutaneous nocardio-
sis, especially in actinomycetoma [2]. This species is more
commonly isolated in areas with tropical or subtropical
climates such as SouthAmerica, Asia, andAfrica. Due to false
diagnosis, rural lifestyles, and poor access to care in these
countries, N. brasiliensis nocardiosis constitutes a real public
health problem that can lead, in the absence of treatment,
to amputations and death in young populations. On the
basis of epidemiological surveys conducted in France, the
number of cases of nocardiosis between 2000 and 2007
according to the French Nocardiosis Observatory (OFN)
was 607 with N. farcinica and N. nova being the most
frequent species [5]. However, no data currently exists on
the phylogenetic relationships between the indigenous N.
brasiliensis strains of tropical origin andnative strains isolated
in France. Routine genus/species identification of Nocardia
was based on macroscopic, microscopic, and biochemical
characteristics. The methods described by Boiron et al.
[6] were used to determine the decomposition of adenine,
casein, hypoxanthine, tyrosine, and xanthine. In addition to
the phenotype-based methods, species-level identification is
mainly genetically based, nowadays. Classically, 16S rRNA
(rrs) gene sequencing is generally used for the species-
level identification [7, 8], but it fails to discriminate among
some species of Nocardia because it does not have enough
polymorphism to differentiate them at the species level.
Multilocus sequence analysis (MLSA) using concatenated
sequences of several housekeeping genes such as superoxide
dismutase A (sodA) and heat shock protein 65 (hsp65)
has been increasingly used to provide higher accuracy and
discriminatory power in the molecular identification of
Nocardia spp. [9, 10]. Indeed, a recent study seeking to
identify newmolecular targets shows that the polymorphism
observed in the sodA gene sequence contains variable regions
that allow the discrimination of closely related Nocardia
species [9].
The aim of the present study was to perform a genetic
characterization and assess the phylogenetic relationships
of Nocardia brasiliensis focusing on using housekeeping
rrs, hsp65, and sodA genes, for 36 autochthonous N.
brasiliensis strains isolated in France and analyzed by
the OFN between 2002 and 2012. Phenotypic charac-
terization was also conducted by assessing antimicrobial
resistance profiles, metabolic profiles, and culture condi-
tion.
2. Materials and Methods
2.1. Bacterial Strains and Culture Media. A collection of 36
human clinical strains ofN. brasiliensis was studied (Table 1).
All strains were identified as such, at species level by the
FrenchNocardiosis Observatory (OFN) by genetic approach.
Moreover, six Nocardia reference strains belonging to N.
brasiliensis clade [9] were also used: N. brasiliensis ATCC
19296T (unknown), N. altamirensis DSM 44997T (karstic
cave), N. boironii DSM 101696T (pus sample), N. iowensis
DSM 45197T (garden soil), N. tenerifensis DSM 44704T
(rhizosphere), and N. vulneris DSM 45737T (human leg
wound). Prior to the assays, strains were cultured 72 hours
in Bennett medium (made in the laboratory) aerobically at
37∘C.
2.2. Growth Test on Culture Media. From 0.5McF bacterial
suspension, bacterial growth was evaluated on three culture
media: (i) bromocresol purple (BCP) (Biome´rieux, Marcy
l’e´toile), (ii) Bennett (made in the laboratory), and (iii)
Middlebrook (Biome´rieux, Marcy l’e´toile). One hundred
microliters from bacterial suspension standardized was inoc-
ulated on the different plate of culture media.The plates were
incubated at 37∘C and the observations were performed at 48,
72, and 96 hours.
2.3. Antimicrobial Susceptibility. The susceptibility of the
isolates to different antimicrobials was determined by disk
diffusion method with a panel of 31 antibiotics (Biorad,
Marnes-la-Coquette France) on Muller Hinton E medium
(Biome´rieux, Marcy l’e´toile, France). Susceptibility testing
was done with amikacin 30𝜇g, gentamycin 15 𝜇g, tobramycin
10 𝜇g, ciprofloxacin 5 𝜇g, levofloxacin 5𝜇g, moxifloxacin
5 𝜇g, minocycline 30 𝜇g, doxycycline 30 𝜇g, tigecycline 15 𝜇g,
cefotaxime 30 𝜇g, ceftriaxone 30 𝜇g, cefepime 30 𝜇g, cefurox-
ime 30 𝜇g, amoxicillin 25𝜇g, amoxicillin + clavulanic acid
20/10 𝜇g, ampicillin 10 𝜇g, ertapenem 10 𝜇g, meropenem
10 𝜇g, imipenem 10 𝜇g, vancomycin 30 𝜇g, pristinamycin
15 𝜇g, erythromycin 15 𝜇g, trimethoprim + sulfamethoxazole
1.25/23.75 𝜇g, rifampicin 30 𝜇g, and linezolid 30 𝜇g.
From visible colonies, bacterial suspension was done in
sterile water, using a cotton swab to obtain a concentration
of 0.5 McFarland according to the Clinical and Laboratory
Standards Institute standard M24-A2 [11]. Seeding was done
according to the swab method. In this latter, the bacterial
inoculum was spread on the agar using a sterile cotton swab
in three different directions. The disks were dispensed with a
dispenser and the plates were incubated at 37∘C for 72 hours
and read manually according to the thresholds defined in the
recommendations of the SFM 2013 [12].
2.4. Substrate Degradation. Themethods of Boiron et al. [6],
Goodfellow et al. [13, 14], and Goodfellow and Lechevalier
[15] were used to determine the decomposition of adenine,
casein, and uric acid [9]. Clinical strains ofN. brasiliensis and
the strains of species belonging to the N. brasiliensis clade
(N. brasiliensis, N. altamirensis, N. iowensis, N. tenerifensis,N.
boironii, and N. vulneris) were tested [9]. Strains N. boironii
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DSM 101696T, N. brasiliensis ATCC 19296T, and N. vulneris
DSM 45737T were incubated at 37∘C, and N. altamirensis
DSM 44997T, N. tenerifensis DSM 44704T, and N. iowensis
DSM 45197T were incubated at 28∘C [9]. The readings were
performed at 3, 7, 10, 14, 17, and 21 days.
2.5. Methods of DNA Extraction. DNA extraction from
Nocardia strains was performed with achromopeptidase
according to the method reported by Rodr´ıguez-Nava et al.
[10]. Colonies were picked off with a loop, and one loopful
was suspended in 200𝜇L of sterile water containing a dozen
glass beads and vortexed for 5 minutes.Themixture was then
incubated for 15 minutes at 70∘C. The suspension supple-
mented with 3.4𝜇L of achromopeptidase (Sigma, Steinheim,
Germany) at 10U/mL was incubated at 55∘C for 15 minutes.
The suspensions were then centrifuged for 5 minutes at
13,000 rpm.The supernatants were stored at −20∘C until use.
2.6. Amplification and Sequencing
Gene rrs. A 606-bp fragment of the rrs gene was ampli-
fied with primers Noc1, 5󸀠-GCTTAACACATGCAAGTCG-
3󸀠, and Noc2, 5󸀠-GAATTCCAGTCTCCCCTG-3󸀠, and PCR
program and reactionmixture were carried out according the
recommendations of Rodr´ıguez-Nava et al. [10].
Gene hsp65. A 441-bp fragment of the hsp65 gene
encoding the 65-kDa heat shock protein was amplified
with primers described by Telenti et al. (TB11: 5󸀠-
ACCAACGATGGTGTGTCCAT-3󸀠 and TB12: 5󸀠-
CTTGTCGAACCGCATACCCT-3󸀠) [16]. PCR program
and reaction mixture were carried out according to the
recommendations of Sa´nchez-Herrera et al. [17].
Gene sodA. A 440-bp fragment of the sodA gene was
amplified and sequenced with primers SodV1 (5󸀠-CAC CAY
WSCAAGCACCA-3󸀠) and SodV2 (5󸀠-CCT TAGCGT TCT
GGT ACT G-3󸀠) where Y = C or T, W = A or T, and S =
C or G. The amplification was also done according to the
recommendations of Sa´nchez-Herrera et al. [17].
All resulting PCR products were sequenced and verified
(Biofidal, Lyon, France).
The breakpoints for identification based in sodA and
hsp65 genes are 99% for each one [17, 18]. For the rrs gene,
a higher breakpoint of 99.6% is used, according to CLSI [19].
2.7. Phylogenetic Analysis. The rrs gene sequences which we
obtained for the 36 clinical isolates of N. brasiliensis and the
reference strains were aligned manually for the comparative
phylogenetic analysis using the Seaview program.
MLSAwas performed using hsp65 and sodA sequences of
the strains collection. The trimmed aligned sequences were
concatenated in the order sodA-hsp65 to generate an 846 bp
sequence using the Seaview program. The Seaview program
was also used to infer the evolutionary trees according to the
neighbour-joining method [20] and Kimura’s two-parameter
model [21]. The robustness of the tree was performed with a
bootstrap of 1000 replicates.
Taking into account the breakpoints for identification
at species level of sodA and hsp65 genes individually, the
breakpoint for concatenated sequence has been also fixed at
99%.
2.8. DNA Polymorphism of rrs, hsp65, and sodA Genes.
The number of haplotypes, the haplotype diversity (Hd),
the number of polymorphic sites, and other variables were
obtained with DnaSP software [22].
3. Results
3.1. Growth on Culture Medium. The three culture media
allowed the growth of clinical strains of N. brasiliensis. The
Bennett medium showed abundant and rapid growth (48
hours). Middlebrookmedium showed strong growth but also
it was slightly slower (72 hours). The BCPmedium presented
interesting results with good rapid growth at 48 hours. N.
brasiliensis clade tested type strains showed similar patterns
to the clinical strains, except that N. boironii had a difficult
growth on BCP and no growth onMiddlebrook; this seems a
peculiarity of this species.
3.2. Antimicrobial Susceptibilities. Eight out of 31 antibiotic
molecules testedwere active on all the strains’ collection: line-
zolid, tigecycline, trimethoprim + sulfamethoxazole, moxi-
floxacin, amikacin, amoxicillin + clavulanic acid, tobramycin,
and gentamycin. Regarding the imipenem and pristinamycin
molecules, resistance was observed on themajority of clinical
isolates of N. brasiliensis (Table 1).
3.3. Degradation of Substrate. Theassimilation test of adenine
and uric acid proved negative for all the strains tested of the
N. brasiliensis clade including clinical and reference ones.The
casein degradation test showed that all clinical strains are
able to metabolize casein except the clinical strain 12.28. In
addition our result showed that some types of strains such
as N. vulneris, N. tenerifensis, N. boironii, and N. iowensis are
also able to degrade casein in the same way as N. brasiliensis
except N. altamirensis. Casein is ultimately a marker that can
be used for the phenotypic identification of theN. brasiliensis
clade and not theN. brasiliensis species as it has been believed
for many years.
3.4. Phylogeny. Primers Noc1 and Noc2 amplified the
expected 606-bp fragment of the rrs gene for all the col-
lection strains. Phylogenetic trees (Figure 1) based upon rrs
showed homogeneity within clinical strains of N. brasiliensis.
For this, the rrs gene is not relevant to show intraspecies
diversity.
In addition, based upon the concatenation of sodA and
hsp65 housekeeping genes, the phylogenetic tree generated
(Figure 2) had several distinct genotypes: (i) genotype 1
containing clinical strains, (ii) genotype 2 harboring some
clinical strains, and (iii) genotype 3 harboring some clinical
strains and N. brasiliensis ATCC 19296T. For the tropical N.
brasiliensis HUJEG01 strain, it is observed that it does not
belong to any of the 3 genotypes and is positioned alone
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N. brasiliensis HUJEG01
M. leprae
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Figure 1: Phylogenetic distribution of rrs gene of 36 N. brasiliensis clinical strains analyzed in this study using neighbour-joining method,
Kimura’s two-parameter model, and bootstrap of 1000. Only values of bootstrap significance greater than 50% (Seaview) were reported.
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Figure 2: Phylogenetic distribution of concatenation sodA-hsp65 genes of 36 N. brasiliensis clinical strains analyzed in this study using
neighbour-joining method, Kimura’s two-parameter model, and bootstrap of 1000. Only values of bootstrap significance greater than 50%
were reported.
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in the tree between genotypes 1 and 2. This distribution
of clinical strains of N. brasiliensis in 3 different genotypes
shows an intraspecies diversity rather important. To better
understand the polymorphism showed by phylogenetic trees,
we studied the percentages of the similarities between the
sequences. The average percentages of similarities based
on the rrs gene (Table 2) range from 99.39% to 99.57%
between the clinical strains and the 2 reference strains of
N. brasiliensis (type and tropical strains). According to the
CLSI, the similarity percentage needed for identification at
species level must be greater than or equal to a threshold
of 99.6% [19]. The clinical strains that showed a similarity
percentage lower than this threshold for both reference
strains ofN. brasiliensiswere anyway considered as belonging
to this species because no higher similarity percentage was
obtained for any other species. In the same way, the N.
vulneris type strain was also revealed to be close to clinical
strains according to the average of percentage of similarity
(98.77%). Between the 2 reference strains of N. brasiliensis
the percentage of similarity is higher, up to 99.82%. The
percentages of similarities based on the concatenation of
the sodA-hsp65 genes (Table 2) decrease and range now
from 97.99% to 99.19% between the clinical strains and the
2 reference strains of N. brasiliensis. Between the type and
reference strains ofN. brasiliensis the percentage of similarity
does not reach 99% this time. The comparison of the 3
genotypes between them (based on the representation of each
genotype by 3 clinical strains) by using sodA-hsp65 genes
shows that genotypes 2 and 3 are closer to each other (98.97%
of similarity). The average of the percentages of similarity
between genotypes 1 and 2 were 97.97%. and 98.28% between
genotypes 1 and 3. Finally this value goes up to 98.97%
between genotypes 2 and 3. This means that the more distant
genotypes between them are 1 and 2 and the closer ones are 2
and 3.
In parallel, an epidemiological study based on the clinical
files was carried out, and the data were presented in Table 1.
In order to know the link between the genetic diversity and
the tropism of the clinical strains, a superposition of data
wasmade between the phylogenetic tree obtained by the con-
catenation of sodA and hsp65 and the tropism of the clinical
strains (Figure 2). Thus, we can see that in genotypes 2 and 3
we have almost all the clinical strains that have a cutaneous
tropism except the 08.188 strain which has a subcutaneous
tropism. Regarding genotype 1 it is more heterogeneous
with various tropism: (i) pulmonary, (ii) cerebral, and (iii)
cutaneous. Regarding the immunocompetence of patients,
we have only 4 patients who have immunodepression factors,
whose strains are in genotype 1 except the 10.93 strain which
is in genotype 3.
3.5. Analysis of rrs, hsp65, and sodA Genes Polymorphism.
The 36 clinical strains and 2 reference strains ofN. brasiliensis
studied showed (i) for rrs gene 16 polymorphic sites sharing
16 haplotypes and showing a Hd of 0.824; (ii) for hsp65 gene,
27 polymorphic sites and up to 22 different haplotypes with
a Hd of 0.927; and, (iii) for sodA gene, up to 29 polymorphic
sites sharing 14 haplotypes having a Hd of 0.885 (Table 3).
4. Discussion
Nocardia spp. are common soil-inhabiting bacteria that fre-
quently infect humans through traumatic injuries or inhala-
tion routes and cause infections, such as actinomycetoma
and nocardiosis, respectively. N. brasiliensis is the main
aetiological agent of actinomycetoma in various countries
[23]. The input data used in this study highlight the existence
of indigenous cases of cutaneous and subcutaneous (such
as actinomycetoma) nocardiosis caused by N. brasiliensis
in France. Moreover, we can observe that N. brasiliensis is
also responsible for severe cases of disseminated nocardiosis
in immunocompromised patients (pulmonary and cerebral
cases).
To determine whether there is an association between
clinical tropism of strains and their genetic profile we per-
formed genetic characterization of 36 indigenous cases of N.
brasiliensis that happened in France.
The three culture media allow the growth of clinical
strains ofN. brasiliensis. However, on Bennett’smediummore
abundant and fast growth (48 hours) was observed. But the
downside of this medium is its inaccessibility in the hospital
because it is not marketable. Middlebrook medium shows
strong growth but also it was slightly slower (72 hours).
This medium is very expensive and not accessible to all
budgets. However, it is an interesting alternative in isolating
Nocardia from a complex sample. It is a selective medium of
Mycobacteria, which promotes the growth of some Nocardia
to the detriment of other external bacteria or commensal
flora that may be in the biological sample analyzed. The
BCP medium, used routinely in hospitals for Gram-negative
bacteria, has interesting results with good fast growth (48
hours). It would therefore be advisable to use it as isolation
medium for urgent cases, by the speed of growth.
Antibiograms results show resistance of most of the clin-
ical strains to imipenem.This can pose therapeutic problems
since it is part of molecules proposed during a phase of a
general treatment for nocardiosis [24]. However, all clinical
strains of N. brasiliensis were sensible to SXT and would be
an effective molecule during treatments. The sensibility of
N. brasiliensis type strain to this antibiotic has already been
observed by Gilquin et al. [9].
Our study confirms that all clinical strains ofN. brasilien-
sis are capable of degrading casein except 12.28 clinical strain.
As shown by Seol et al. theN. brasiliensis type strain is able to
degrade casein as well [25]. However, the test on the reference
strains reveals that N. vulneris, N. tenerifensis, N. boironii,
and N. iowensis are also capable of degrading casein in the
same way as N. brasiliensis, as also shown by Gilquin et al.
[9]. This type of test is used in some countries without the
necessary molecular biology tools to identify N. brasiliensis.
But, now, they must be aware that with this test we target
several species of clade N. brasiliensis. So, it is no longer a
criterion of identification proper to N. brasiliensis.
Phylogenetic tree based on the rrs gene sequence of our
collection showed a low genetic diversity resulting in low
polymorphism sequence. In addition, we can note that N.
vulneris DSM 45737T, identified as a new species by Lasker
et al., present a genetic sequence very close to N. brasiliensis
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Table 3: DNA polymorphism of rrs, hsp65, and sodA genes from clinical N. brasiliensis strains isolated in France.
Nocardia species Genes (bp)a Number of haplotypes(Hd, S2, SD)b
Number of of
polymorphic sites
N. brasiliensis
(𝑁 = 38: 36 clinical strains and 2 reference strains)
rrs (569) 16 (0.824, 0.00300, 0.055) 16
hsp65 (401) 22 (0.927, 0.00087, 0.029) 27
sodA (406) 14 (0.885, 0.00080, 0.028) 29
aResulting fragment size without the primers sequences; bHd: haplotype (gene) diversity, S2: variance of haplotype diversity, and SD: standard deviation of
haplotype diversity.
strains [26]with percentages of similarities on average greater
than 98%.
Analysis of the phylogenetic tree (Figure 2) based on the
MLSA by the concatenation of sodA and hsp65 housekeeping
genes showed that the isolates are surprisingly classified
according to 3 genotypes. These groups were formed upon
similarity percentages and existing phylogenetic distances
between the sequences of the strains studied. Genotype 1 con-
cerns a well-defined cluster containing 9 clinical strains only
which is sustained by a bootstrap of 81%.This genotype hosts
all the cases of pulmonary forms (3), the sole cerebral form,
and almost all the cases of immunocompromised patients (3
out of 4). Moreover, eight out of twelve strains susceptible
to imipenem can be found in this group. There is just one
remaining strain in this group not presenting this kind of
susceptibility. The reason may be an acquired resistance to
this drug due to a previous treatment. This well-defined
genotype evokes the possible existence of another species or
a strong variability in this case. This may have been caused
by environmental pressures in the ecosystem of these isolates
which may have resulted in the selection of strains that may
have acquired, by mutations or genetic transfer with other
microorganisms, new virulence characters different from that
of the strain type N. brasiliensis. Regarding genotypes 2 and
3, they include clinical strains and N. brasiliensis ATCC
19296T type strain. However, the discrimination between
these 2 genotypes is less clear than that with genotype 1
because of being in weak bootstrap that is less than 50. The
genetic differences do not allow distinguishing them properly
and their phenotypic behavior remains similar. Then, it
would be interesting to study on another gene capable of
generating more divergences, for example, gyrB and rpoB
genes, which have already successfully been used for studying
the polymorphism of some other Nocardia species [27, 28].
Concerning the percentage of similarity between the type
and tropical strain of N. brasiliensis, it is 99.82% according to
the rrs and goes down to 98.51% with the concatenation of
sodA and hsp65. The fact of highlighting a greater dissimilar-
ity with the concatenation between the type and tropical N.
brasiliensis strain shows the advantage of the use of 2 markers
like sodA and hsp65 vis-a`-vis the rrs. The discriminatory
power of these two genesmay be explained by the presence of
more polymorphic sites (hsp65: 27; sodA: 29) than in the case
of rrs gene (16) and also by having Hd values higher than that
of rrs gene (hsp65: 0.927; sodA: 0.885; rrs: 0.824).
It would be interesting to identify the genes involved
in the virulence of different genotypes, including those of
actinomycetoma. Interesting leads can be considered: (i) as
identification of virulence genes expressed using the RNAseq
method or (ii) to identify noncoding RNAs [23]. In addition,
to genomically distinguish N. brasiliensis and N. vulneris
a specific PCR to N. vulneris, using a specific gene of the
species, should be developed.
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